Figure 39: Endpoints- Clinical Trials in Central Nervous System
Disorders, Epilepsy, Completed Phase III Clinical Trials Classified Based on Secondary Endpoints, Global, 2000-2010 97
review of the companies actively partnering central nervous system
We can see this structural difference when we look at a mutant's nerve fiber that passes all the way from the peripheral to the central nervous system
," he says.
This Frost & Sullivan research service titled "European Central Nervous System
(CNS) Therapeutics Markets" provides a detailed analysis of various neurological and psychiatric disorders.
The compound dissolves more easily in water, he said, which impedes its ability to enter the brain's fatty tissues and disturb the central nervous system
Bodor also formed the basis of some of Pharmos' products currently in development, including Loteprednol etabonate currently in Phase III trials for ocular inflammation, Adaprolol Maleate in Phase I/II trials for glaucoma and Estradiol CDS in Phase I/II trials for post menopausal central nervous system
The scientists are transplanting the oligos from healthy animals into the central nervous system
(CNS) of myelin-deficient ones and witnessing the spread of the myelin-makers, with no evidence of transplant rejection.
Roberts is a world-renowned chemist with more than 30 years of drug development experience at both large pharmaceutical and biotech companies specializing in the treatment of disorders of the central nervous system
The results overturn a long-accepted theory that central nervous system
nerve cells in mammals lose the ability to reproduce before or soon after an individual's birth.
My conversations with Patrick Cashman have convinced me that Lundbeck will be another significant player in the continued growth of the bio-pharmaceutical industry in this region with the potential to develop important new products to treat central nervous system
disorders and improve patients' lives.
Instead, scientists have accumulated evidence that HIV in the central nervous system
mainly replicates inside two types of related cells: macrophages (scavenger cells that have migrated from the blood) and microglial cells (the resident immune cells of the brain and spinal cord).
Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system
disorders, today announced that it will present at the BIO CEO & Investor Conference 2007 on Tuesday, February 13, 2007, at 11:15 a.
Beyond facilitating unprecedented studies of the human central nervous system
, the accomplishment may provide an ethical end-run around controversial transplants of fetal brain cells.
Eti Yoles, Proneuron's VP R&D, added: "Developing PN277 as a potential treatment for PD, in parallel to our efforts to develop it for ischemic stroke and other indications, is a key element toward achieving our mission to accelerate the development of potentially effective treatments for un-curable central nervous system
They discovered that injecting healthy mice with the protein caused the mice to develop a central nervous system
disorder similar to MS.